BARCELONA — Minocycline, an inexpensive oral therapy with a proven safety record, may have a new role to treat patients with possible multiple sclerosis (MS), a new study suggests. The antibiotic has ...

Minocycline is not used as a second-line antimicrobial for anxiety vulgaris. Plum patients suffer doses of 200 mg minocycline to mg tightly to control your acne. The brasserie duration of treatment ...

During an epidemic caused by sulfonamide-resistant group A Neisseria meningitidis (A $Su^{R}$ strain), rifampin (600 mg per day for four days) or minocycline (100 mg ...

A low-dose (40 mg) modified formulation of minocycline hydrochloride (DFD-29) was better tolerated and more effective than doxycycline and placebo in patients with moderate to severe papulopustular ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for a ...

Treatment with the antibiotic minocycline failed to slow cognitive decline or functional impairment in patients with mild Alzheimer’s disease, according to a November 18 paper in JAMA Neurology.

Multiple lines of evidence suggest that a dysfunction in the glutamatergic neurotransmission via the N-methyl-D-aspartate (NMDA) receptors might be involved in the pathophysiology of schizophrenia ...

SCOTTSDALE, Ariz., Oct. 20, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on the selling and ...

SCOTTSDALE, Ariz., March 24, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing ...

Please provide your email address to receive an email when new articles are posted on . During the course of 6 months, once-monthly triple antibiotic treatment helped improve, but did not clear, ...